Home > Clinical Trials
Check All Search

Saved trials

NOT_YET_RECRUITING
NCT06916520
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
300 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)


Percutaneous Coronary Intervention (PCI)
ACTIVE_NOT_RECRUITING
NCT05767723
Platelet Sub-study of the Neomindset Trial
48 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Acute Coronary Syndrome
TERMINATED
NCT04593784
Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults
41 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE2)
Healthy
NOT_YET_RECRUITING
NCT06912763
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
250 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Fibrosis Syndrome


Lymphedema


Head &Amp; Neck Cancer


Fibrosis
ACTIVE_NOT_RECRUITING
NCT06449469
The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)
352 Enrollment(s)
2 Study location(s)
INTERVENTIONAL (NA)
Aortic Valve Stenosis


Cardiovascular Diseases


Heart Diseases


Heart Valve Diseases


Valve Disease, Aortic
COMPLETED
NCT03488420
Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE
136 Enrollment(s)
9 Study location(s)
OBSERVATIONAL (None)
Atrial Fibrillation and Flutter


Valvular Heart Disease
COMPLETED
NCT01892371
Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
73 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
FLT3 Gene Mutation Negative


FLT3 Internal Tandem Duplication Positive


Recurrent Acute Myeloid Leukemia


Recurrent Chronic Myelomonocytic Leukemia


Recurrent Myelodysplastic Syndrome


Refractory Acute Myeloid Leukemia


Refractory Chronic Myelomonocytic Leukemia


Refractory Myelodysplastic Syndrome
RECRUITING
NCT05868226
PRE-I-SPY Phase I/Ib Oncology Platform Program
124 Enrollment(s)
7 Study location(s)
INTERVENTIONAL (PHASE1)
HER2-positive Breast Cancer


Metastatic Cancer


Metastatic Breast Cancer


Metastatic


HER2-positive Metastatic Breast Cancer


HER2 Mutation-Related Tumors


HER-2 Protein Overexpression


HER2-negative Breast Cancer


Triple Negative Breast Cancer


HR Positive


Hormone Receptor-positive Breast Cancer


Estrogen Receptor Positive Tumor


Progesterone Receptor-positive Breast Cancer


Hormone Receptor Negative Breast Carcinoma


Solid Tumor


Solid Tumor, Adult


Solid Carcinoma


HER2 Low Breast Cancer


HER2 Low Breast Carcinoma


ER Positive Breast Cancer


PR-positive Breast Cancer